- Home
- PMCB vs NCRA Comparison
PMCB vs NCRA Comparison
Compare PMCB & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- NCRA
- Stock Information
- Founded
- PMCB 1996
- NCRA 2002
- Country
- PMCB United States
- NCRA Taiwan
- Employees
- PMCB N/A
- NCRA N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- NCRA Farming/Seeds/Milling
- Sector
- PMCB Health Care
- NCRA Consumer Staples
- Exchange
- PMCB Nasdaq
- NCRA Nasdaq
- Market Cap
- PMCB 15.8M
- NCRA 15.4M
- IPO Year
- PMCB N/A
- NCRA N/A
- Fundamental
- Price
- PMCB $1.73
- NCRA $1.14
- Analyst Decision
- PMCB
- NCRA
- Analyst Count
- PMCB 0
- NCRA 0
- Target Price
- PMCB N/A
- NCRA N/A
- AVG Volume (30 Days)
- PMCB 36.9K
- NCRA 5.7K
- Earning Date
- PMCB 09-17-2024
- NCRA 08-14-2024
- Dividend Yield
- PMCB N/A
- NCRA N/A
- EPS Growth
- PMCB N/A
- NCRA N/A
- EPS
- PMCB 0.54
- NCRA N/A
- Revenue
- PMCB N/A
- NCRA $26,403,874.00
- Revenue This Year
- PMCB N/A
- NCRA N/A
- Revenue Next Year
- PMCB N/A
- NCRA N/A
- P/E Ratio
- PMCB $3.29
- NCRA N/A
- Revenue Growth
- PMCB N/A
- NCRA 33.73
- 52 Week Low
- PMCB $1.39
- NCRA $0.73
- 52 Week High
- PMCB $2.58
- NCRA $1.60
- Technical
- Relative Strength Index (RSI)
- PMCB 47.06
- NCRA 59.29
- Support Level
- PMCB $1.72
- NCRA $1.06
- Resistance Level
- PMCB $1.95
- NCRA $1.10
- Average True Range (ATR)
- PMCB 0.24
- NCRA 0.10
- MACD
- PMCB -0.01
- NCRA 0.01
- Stochastic Oscillator
- PMCB 36.67
- NCRA 74.29
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.